Investing.com - JCR Pharmaceuticals reported on Wednesday second quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
JCR Pharmaceuticals announced earnings per share of ¥-3.3 on revenue of ¥6.0. Analysts polled by Investing.com anticipated EPS of ¥-1.2 on revenue of ¥7.73B.
JCR Pharmaceuticals shares are down 16.97% from the beginning of the year and are trading at ¥2,123.0 , down-from-52-week-high.
JCR Pharmaceuticals follows other major Healthcare sector earnings this month
JCR Pharmaceuticals's report follows an earnings missed by Chugai Pharmaceutical on Monday, who reported EPS of ¥41.21 on revenue of ¥225.3B, compared to forecasts EPS of ¥49.44 on revenue of ¥288.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar